Stockhub

CANbridge Pharmaceuticals Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 16:4716:47, 22 September 2022 95.149.241.133 talk 1,343 bytes +1,343 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide. The company offers Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome; NERLYNX (Neratinlib), a potent irreversible tyrosine kinase inhibitor for HER2-positive breast cancer; and Caphosol Mouth Rinse for temporary..."
Retrieved from "https://stockhub.co/research/CANbridge_Pharmaceuticals_Inc."